0RU5

Bergenbio Asa News - 0RU5

Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
US$29.56
Real-time Level 2 for London Stock Exchange
Monthly Subscription
for only
US$77.61
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
US$88.69
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Bergenbio Asa 0RU5 London Ordinary Share NO0010650013 BERGENBIO ORD SHS
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 46.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
46.00 46.00
more quote information »

Recent News

Date Time Source Heading
4/19/202100:26PRNUSBerGenBio Announces Update From Investigational Phase II..
4/19/202100:24PRNUSBerGenBio Announces Update From Investigational Phase II..
3/06/202107:59PRNUSBerGenBio Presents Preclinical COVID-19 Data at Annual..
3/04/202100:22PRNUSBergenbio Closes Recruitment Into Trial Assessing..
2/17/202100:20PRNUSBerGenBio To Present Preclinical Covid-19 Data At The..
2/17/202100:19PRNUSBerGenBio To Present Preclinical Covid-19 Data At The..
12/06/202013:23PRNUSBerGenBio Presents Updated Clinical Data From Two Phase II..
12/06/202013:22PRNUSBerGenBio Presents Updated Clinical Data From Two Phase II..
11/11/202007:21PRNUSBerGenBio Presents Phase II Bemcentinib Combination Study in..
11/11/202007:19PRNUSBerGenBio Presents Phase II Bemcentinib Combination Study in..
10/23/202000:18PRNUSBerGenBio Virtual R&D Day - 06 November 2020
10/23/202000:15PRNUSBerGenBio Virtual R&D Day - 06 November 2020
9/18/202000:19PRNUSBerGenBio to Present At Sachs annual biotech In europe forum
9/01/202000:21PRNUSBerGenBio to Present at Upcoming Investor Conferences
9/01/202000:19PRNUSBerGenBio to Present at Upcoming Investor Conferences
8/18/202000:32PRNUSBerGenBio ASA: Results for the Second Quarter and First Half..
8/18/202000:29PRNUSBerGenBio ASA: Results for the Second Quarter and First Half..
8/10/202000:21PRNUSBERGENBIO ASA: Invitation to second quarter 2020 results..
8/10/202000:17PRNUSBERGENBIO ASA: Invitation to second quarter 2020 results..
7/28/202010:56PRNUSUpdate On Bemcentinib's Involvement in Potential Treatment..
7/28/202010:53PRNUSUpdate On Bemcentinib's Involvement in Potential Treatment..
7/20/202000:20PRNUSBerGenBio Announces First Patient Dosed in Recurrent..
7/20/202000:17PRNUSBergenbio Announces First Patient Dosed in Recurrent..
7/07/202000:29PRNUSBerGenBio to Present at Digital Novel Coronavirus Investment..
7/07/202000:25PRNUSBerGenBio to Present at Digital Novel Coronavirus Investment..
6/25/202012:30PRNUSBerGenBio Announces Positive Interim Clinical and..
6/25/202012:28PRNUSBerGenBio Announces Positive Interim Clinical and..
6/24/202000:27PRNUSBerGenBio Announces Change to Presentation Time at Next Gen..
6/24/202000:24PRNUSBerGenBio Announces Change to Presentation Time at Next Gen..
6/23/202000:10PRNUSBerGenBio to Present at the Upcoming Virtual European..
6/15/202000:46PRNUSBerGenBio to Present Top Line Translational Phase II Data..
6/15/202000:45PRNUSBerGenBio to Present Top Line Translational Phase II Data..
6/02/202000:15PRNUSBerGenBio Confirms First Covid-19 Patient Dosed With..
6/02/202000:12PRNUSBergenbio Confirms First Covid-19 Patient Dosed With..
5/19/202000:22PRNUSBerGenBio ASA: Results for the First Quarter 2020
5/19/202000:20PRNUSBerGenBio ASA: Results for the First Quarter 2020
5/13/202000:23PRNUSBerGenBio ASA: Invitation to First Quarter 2020 Results..
5/13/202000:20PRNUSBerGenBio ASA: Invitation to First Quarter 2020 Results..
See more news about this stock »
Your Recent History
LSE
0RU5
Bergenbio ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210512 17:54:20